Intracranial Pressure (ICP) Monitoring Devices - Global Strategic Business Report

Global Intracranial Pressure (ICP) Monitoring Devices Market to Reach $2.8 Billion by 2030

The global market for Intracranial Pressure (ICP) Monitoring Devices estimated at US$1.5 Billion in the year 2022, is projected to reach a revised size of US$2.8 Billion by 2030, growing at a CAGR of 7.8% over the analysis period 2022-2030. Invasive, one of the segments analyzed in the report, is projected to record 7.5% CAGR and reach US$2.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Non-Invasive segment is readjusted to a revised 9.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $412.8 Million, While China is Forecast to Grow at 11.9% CAGR

The Intracranial Pressure (ICP) Monitoring Devices market in the U.S. is estimated at US$412.8 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$627.6 Million by the year 2030 trailing a CAGR of 11.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.1% and 6.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Select Competitors (Total 36 Featured) -

• HaiWeiKang
• HeadSense Medical
• Integra LifeSciences
• Johnson and Johnson
• Medtronic
• Raumedic
• Sophysa Ltd
• Spiegelberg
• Vittamed

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year